These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2987734)

  • 1. Sigma opioid receptors; SKF-10,047 update.
    Khazan N; Young GA; el-Fakahany EE; Hong O; Calligaro D
    Neuropeptides; 1985 Feb; 5(4-6):339-40. PubMed ID: 2987734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties.
    Khazan N; Young GA; El-Fakany EE; Hong O; Calligaro D
    Neuropharmacology; 1984 Aug; 23(8):983-7. PubMed ID: 6090969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism.
    Young GA; Khazan N
    Neuropharmacology; 1984 Oct; 23(10):1161-5. PubMed ID: 6097833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential tolerance to repeated daily injections of N-allylnormetazocine and its enantiomers in the rat.
    Young GA; Hong O; Khazan N
    Neuropharmacology; 1987 May; 26(5):463-7. PubMed ID: 3037416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential stereospecific effects of mu, kappa, and sigma opioid agonists on cortical EEG power spectra in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1983 Apr; 43():190-5. PubMed ID: 6308453
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes: an opioid/sigma receptor?
    Tsao LI; Su TP
    Synapse; 1997 Feb; 25(2):117-24. PubMed ID: 9021892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog.
    Vaupel DB
    Eur J Pharmacol; 1983 Sep; 92(3-4):269-74. PubMed ID: 6313397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms.
    Stafford I; Tomie A; Wagner GC
    Drug Alcohol Depend; 1983 Oct; 12(2):151-6. PubMed ID: 6317323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
    Samovilova NN; Iarygin KN; Vinogradov VA
    Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
    Nabeshima T; Hiramatsu M; Kameyama T
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
    Ceci A; Smith M; French ED
    Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute and chronic administration of (+)SKF 10,047 on body temperature in the rat.
    Bejanian M; Pechnick RN; George R
    NIDA Res Monogr; 1989; 95():492-3. PubMed ID: 2561840
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiating opioids by their pupillary effects in the rat.
    Robin M; Kirby A; Messner S; Geller EB; Adler MW
    Life Sci; 1985 Apr; 36(17):1669-77. PubMed ID: 2985902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of [3H](-)-SKF-10,047 with brain sigma receptors: characterization and autoradiographic visualization.
    Zukin SR; Tempel A; Gardner EL; Zukin RS
    J Neurochem; 1986 Apr; 46(4):1032-41. PubMed ID: 3005501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of kappa, sigma and partial mu narcotic receptor agonists on rat brain acetylcholine turnover.
    Wood PL; Rackham A
    Neurosci Lett; 1981 Apr; 23(1):75-80. PubMed ID: 6262686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
    Gosnell BA; Levine AS; Morley JE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of non-opioid sigma binding with (d)3H-SKF 10047 in guinea pig brain.
    Mickelson MM; Lahti RA
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):255-63. PubMed ID: 2986252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.